Zerion Pharma A/S — Credit Rating and Financial Key Figures

Zerion Pharma A/S (CVR number: 40169229) is a company from KØBENHAVN. The company reported a net sales of 3.5 mDKK in 2024, demonstrating a decline of -3 % compared to the previous year. The operating profit percentage was poor at -384.4 % (EBIT: -13.3 mDKK), while net earnings were -220 kDKK. The profitability of the company measured by Return on Assets (ROA) was -5.3 %, which can be considered poor and Return on Equity (ROE) was -2.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -18.9 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Zerion Pharma A/S's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.